Related Experiment Video
Updated: Aug 8, 2026
12:05
Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
Summary
Hemoglobin level and bone marrow cellularity are key prognostic indicators in myelofibrosis. Higher hemoglobin and hypercellular bone marrow correlate with significantly longer survival in patients.
Area of Science:
- Hematology
- Oncology
Background:
- Myelofibrosis is a serious bone marrow disorder.
- Prognostic factors are crucial for patient management.
Purpose of the Study:
- To evaluate the prognostic significance of spleen size, hemoglobin (Hb), platelet count, and bone marrow cellularity in myelofibrosis patients.
Main Methods:
- Retrospective analysis of 33 myelofibrosis patients.
- Assessment of spleen size, Hb, platelet count, and bone marrow cellularity.
- Correlation of these parameters with patient survival.
Main Results:
- Hemoglobin level and bone marrow cellularity were significant prognostic indicators (P<0.01 and P<0.001, respectively).
- Patients with Hb >10 g/dl had >110 months median survival vs. 22.5 months for Hb <10 g/dl.
- Hypercellular bone marrow correlated with >110 months median survival vs. 20.5 months for normo-/hypocellular marrow.
- Significant correlation (P<0.01) found between bone marrow cellularity and Hb level.
Conclusions:
- Hemoglobin and bone marrow cellularity are valuable prognostic markers in myelofibrosis.
- These factors can guide treatment strategies and patient counseling.
